- Home
- ATHA vs EJH Comparison
ATHA vs EJH Comparison
Compare ATHA & EJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- EJH
- Stock Information
- Founded
- ATHA 2011
- EJH 2018
- Country
- ATHA United States
- EJH China
- Employees
- ATHA N/A
- EJH N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- EJH Other Consumer Services
- Sector
- ATHA Health Care
- EJH Consumer Discretionary
- Exchange
- ATHA Nasdaq
- EJH Nasdaq
- Market Cap
- ATHA 10.6M
- EJH 9.5M
- IPO Year
- ATHA 2020
- EJH 2021
- Fundamental
- Price
- ATHA $0.42
- EJH $2.77
- Analyst Decision
- ATHA Buy
- EJH
- Analyst Count
- ATHA 4
- EJH 0
- Target Price
- ATHA $11.25
- EJH N/A
- AVG Volume (30 Days)
- ATHA 239.8K
- EJH 189.6K
- Earning Date
- ATHA 07-31-2025
- EJH 01-01-0001
- Dividend Yield
- ATHA N/A
- EJH N/A
- EPS Growth
- ATHA N/A
- EJH N/A
- EPS
- ATHA N/A
- EJH N/A
- Revenue
- ATHA N/A
- EJH $50,110,199.00
- Revenue This Year
- ATHA N/A
- EJH N/A
- Revenue Next Year
- ATHA N/A
- EJH N/A
- P/E Ratio
- ATHA N/A
- EJH N/A
- Revenue Growth
- ATHA N/A
- EJH N/A
- 52 Week Low
- ATHA $0.22
- EJH $2.22
- 52 Week High
- ATHA $3.67
- EJH $775.00
- Technical
- Relative Strength Index (RSI)
- ATHA 73.73
- EJH 33.75
- Support Level
- ATHA $0.29
- EJH $2.43
- Resistance Level
- ATHA $0.32
- EJH $2.88
- Average True Range (ATR)
- ATHA 0.03
- EJH 0.26
- MACD
- ATHA 0.01
- EJH 0.54
- Stochastic Oscillator
- ATHA 78.16
- EJH 54.94
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving the orders online and providing the services offline. Its operations are organized into five reportable segments: installation and maintenance services, housekeeping services, senior care services, sales of pharmaceutical products and educational consulting services. The group's principal source of revenue comes from the Installation and Maintenance segment, followed by Housekeeping and Senior care services segment.